MarketLens
Sign Up

What Does Stopping GLP-1 Treatment Really Mean for Your Heart

6 months ago
SHARE THIS ON:

What Does Stopping GLP-1 Treatment Really Mean for Your Heart

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

Beyond the Scale: Orderly Wellness and Veo Health Team Up to Give GLP-1 Patients the Full Picture

OrderlyMeds and Veo Health announced a strategic partnership to pair GLP-1 and peptide treatments with Veo's metabolic health monitoring, aiming to give patients a fuller picture beyond weight. The co...
Stock News2 weeks ago

GLP-1 weight loss drugs effective even at low starter doses

GLP-1 obesity drugs showed weight loss at low starter doses, with significantly less nausea than at higher doses, per a new study. Patients staying on low doses may trade reduced efficacy for improved...
Stock News2 months ago

Ionis, AstraZeneca Pivotal Heart Disease Drug Flunks

Ionis and AstraZeneca's Phase 3 study of eplontersen for ATTR-CM failed to meet its primary efficacy endpoint, a major setback for the heart disease drug.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Generac, Amazon strike $2.4 billion long-term generator supply deal

Stock News2 hours ago

A Broad-Based Earnings Growth Picture as Revisions Stay Positive

Stock News2 hours ago

Why Intel Stock Jumped Today

Stock News2 hours ago

LARRY KUDLOW: Prosperity is as American as apple pie

Stock News2 hours ago

Diamondback Energy Inc (FANG) Stock Down 8.0% -- Now Undervalued? GF Score: 61/100